Abstract
One of the main drivers for neovascularization in age-related macular degeneration is activation of innate immunity in the presence of macrophages. Here, we demonstrate that T helper cell type 2 cytokines and, in particular, IL-4 condition human and murine monocyte phenotype toward Arg-1(+), and their subsequent behavior limits angiogenesis by increasing soluble fms-like tyrosine kinase 1 (sFlt-1) gene expression. We document that T helper cell type 2 cytokine-conditioned murine macrophages neutralize vascular endothelial growth factor-mediated endothelial cell proliferation (human umbilical vein endothelial cell and choroidal vasculature) in a sFlt-1-dependent manner. We demonstrate that in vivo intravitreal administration of IL-4 attenuates laser-induced choroidal neovascularization (L-CNV) due to specific IL-4 conditioning of macrophages. IL-4 induces the expression of sFlt-1 by resident CD11b(+) retinal microglia and infiltrating myeloid cells but not from retinal pigment epithelium. IL-4-induced suppression of L-CNV is not prevented when sFlt-1 expression is attenuated in retinal pigment epithelium. IL-4-mediated suppression of L-CNV was abrogated in IL-4R-deficient mice and in bone marrow chimeras reconstituted with myeloid cells that had undergone lentiviral-mediated shRNA silencing of sFlt-1, demonstrating the critical role of this cell population. Together, these data establish how lL-4 directly drives macrophage sFlt-1 production expressing an Arg-1(+) phenotype and support the therapeutic potential of targeted IL-4 conditioning within the tissue to regulate disease conditions such as neovascular age-related macular degeneration.
Original language | English |
---|---|
Journal | American Journal of Pathology |
DOIs | |
Publication status | Published - 12 Jun 2015 |
Bibliographical note
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.Fingerprint
Dive into the research topics of 'IL-4 Regulates Specific Arg-1(+) Macrophage sFlt-1-Mediated Inhibition of Angiogenesis'. Together they form a unique fingerprint.Equipment
-
Wolfson Bioimaging Facility
Mark Jepson (Manager)
Faculty of Life SciencesFacility/equipment: Facility
Profiles
-
Professor Andrew David Dick
- Bristol Medical School (THS) - Professor of Ophthalmology
- School of Cellular and Molecular Medicine - Professor of Ophthalmology
- Elizabeth Blackwell Institute for Health Research
- Infection and Immunity
- Ophthalmology
- Bristol Neuroscience
Person: Academic , Member
-
Dr Lindsay B Nicholson
- School of Cellular and Molecular Medicine - Reader in Research
- Infection and Immunity
- Ophthalmology
Person: Academic , Member, Group lead